Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats
- 1 August 2002
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 43 (2) , 181-187
- https://doi.org/10.1016/s0028-3908(02)00082-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A role for glutamate in the treatment of anxiety and depression: Focus on group I metabotropic glutamate (mGlu) receptorsDrugs of the Future, 2002
- Current perspectives on the development of non-biogenic amine-based antidepressantsPharmacological Research, 2001
- Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedgesBritish Journal of Pharmacology, 2001
- Selective mGluR5 antagonists MPEP and SIB‐1893 decrease NMDA or glutamate‐mediated neuronal toxicity through actions that reflect NMDA receptor antagonismBritish Journal of Pharmacology, 2000
- Frequency of Anxiety Disorders in Psychiatric Outpatients With Major Depressive DisorderAmerican Journal of Psychiatry, 2000
- Activation of group I mG1uRs potentiates NMDA responses in rat hippocampal slicesNeuroscience Letters, 1996
- The metabotropic glutamate receptors: Structure and functionsNeuropharmacology, 1995
- The Excitatory Amino Acid Receptors: Their Classes, Pharmacology, and Distinct Properties in the Function of the Central Nervous SystemAnnual Review of Pharmacology and Toxicology, 1989
- Modulation of Glutamate Receptors: Molecular Mechanisms and Functional ImplicationsAnnual Review of Pharmacology and Toxicology, 1989
- The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials1Pharmacology Biochemistry and Behavior, 1983